1. We have studied the plasma lipoprotein abnormalities in obstructive jaundice to test the hypothesis that the abnormalities would correlate with plasma lecithin-cholesterol acyltransferase activity.
Introduction
In obstructive jaundice changes in plasma lipid and lipoproteins are similar to those found with familial deficiency of the plasma enzyme lecithincholesterol acyltransferase (LCAT: EC 2.3.1.43) (Mclntyre, Calandra & Pearson, 1974) . LCAT catalyses the production of cholesteryl ester and lysolecithin by transferring a fatty acid from the ß position of lecithin to the 3-/?-hydroxyl group of free cholesterol (Glomset, 1968) . As one might expect plasma free cholesterol and lecithin are elevated in patients with familial LCAT deficiency and cholesteryl ester and lysolecithin con centrations are low (Norum & Gjone, 1967) . Similar, though not identical, changes are also found in the plasma amounts of these substances in many patients with obstructive jaundice (Mclntyre, Harry & Pearson, 1975) .
Plasma triglyceride concentrations tend to be elevated in both conditions, but the excess of tri glyceride is not always in very-low-density lipo proteins (VLDL). Instead it may be found in the low-density lipoprotein (LDL) fraction, which may contain large triglyceride-rich particles, particles 369 the size of normal LDL, and also lipoprotein X (LP-X), an abnormal lipoprotein rich in free cholesterol and lecithin but which contains little or no triglyceride (Glomset, Nichols, Norum, King & Forte, 1973; Muller, Fellin, Lambrecht, Agostini, Wieland, Rost & Seidel, 1974) . High-density lipo protein (HDL) is absent on electrophoresis in LCAT deficiency and is often absent in liver disease, but HDL of abnormal composition and structure can be isolated by preparative ultracentrifugation in both conditions (Forte, Nichols, Glomset & Norum, 1974) .
The similarity of the changes which may occur in obstructive jaundice to those found in familial LCAT deficiency suggests that alterations in enzyme activity may play a key role in their development. But patients with obstructive jaun dice may show high, normal or low LCAT activity . We have therefore made detailed studies of such patients to test the hypothesis that their lipoprotein changes would reflect the LCAT activity found in the plasma.
Materials and methods
Sixteen inpatients (ten female, six male) with a wide range of plasma cholesteryl ester concentration were studied, all having definite evidence of obstructive jaundice. One of them (S.S.) was studied on two occasions separated by 13 months. The diagnosis was confirmed by liver biopsy, radiology and/or surgery. Seven had intrahepatic cholestasis and nine large-duct obstruction (Table  1) . Nine normal subjects (six male and three female) were also studied for comparison.
Blood was collected after an overnight fast with ethylenediamine tetra-acetic acid (2-7mmol/i) used as an anticoagulant. The plasma was divided into two portions. Ellman's reagent (5,5-dithio-2-nitrobenzoic acid) was added to one, at a final concentration of 1-4 mol/1, to block LCAT activity (Stokke & Norum, 1971 ). This portion was used for whole plasma lipid estimations, for the pre paration of the lipoprotein fractions and for the measurement of LCAT by the method of Stokke & Norum (1971) . The other portion was used for liverfunction tests and lipoprotein electrophoresis.
Assay of lecithin-cholesterol acyltransferase
LCAT activity was measured in all subjects by the method of Stokke & Norum (1971 large batch of normal plasma was used in each assay to check reproducibility. Incubations were done in duplicate and the difference between duplicates did not exceed 11-596 (mean 9-6) of the higher of the two values. Incubations were terminated by the addition of chloroform/methanol (2:1, v/v), which also served to extract the lipids. Free cholesterol and cholesteryl esters were separated by thin-layer chromatography (solvent system hexane/diethyl ether/acetic acid, 76:30:1, by vol.) and their radio activity was counted by using a Philips liquid scintillation analyser with automatic quench cor rection. The results are expressed as nmol of free cholesterol esterified h _1 ml -1 .
Electrophoresis
Electrophoresis of plasma lipoproteins was performed on agarose slides in sodium barbitone/ acetate buffer (5 mmol/1), pH 8-6. Lipoproteins were prestained with nitroblue tetrazolium (Segal, Putman, Levi & Lewis, 1974) .
Lipid and protein determinations
Lipids were extracted by the method of Folch, Lees & Sloane-Stanley (1957) . Free and total cholesterol were assayed by gas-liquid chromato graphy (Blomhoff, 1973) ; cholesteryl esters were calculated as the differences between total and free cholesterol. Total cholesteryl ester content of the lipoproteins was calculated by multiplying the ester cholesterol value by 1-68. Phospholipids were measured as inorganic phosphate (Marinetti, 1962) ; total phospholipid content of the lipo proteins was calculated by multiplying the lipid phosphorus value by 25. Protein was measured by the method of Lowry, Rosebrough, Farr & Randall (1951) with bovine serum albumin used as the standard, and triglyceride by Auto-analyzer by the method of Cramp & Robertson (1968) ; the calculation of total triglyceride content of lipo proteins included the mass of glyceride glycerol. LDL (d 1006-1-063) and HDL (d 1 -063-1-210) were isolated by differential ultracentrifugation (Hatch & Lees, 1968) . Whole lipoprotein fractions were analysed chemically and by immunological reactivity, and were examined by electron microscopy; they were also filtered through a 2-5 cm x 100 cm column of 2% agarose (Bio-Gel A 50 m, 100-200 mesh). Some of the HDL fractions were filtered through Sephadex G-200. Samples were eluted at 4°C with Tris/HCl (10 mmol/1) in sodium chloride solution (140 mmol/1), pH 7-4, containing EDTA (1 mmol/1) and sodium azide (3 mmol/1). The eluted peaks were analysed in the same way as whole lipoprotein fractions.
Isolation of lipoproteins
We aimed to produce fractions of lipoproteins with little contamination. We calculated the total lipoprotein within a fraction (expressed per 100 ml of plasma) by adding together the results obtained for individual components of the lipoproteins, all of which were corrected to 100 ml of plasma, without correction for losses. The recovery of the various subfractions (calculated by comparing the sum of their lipid contents with total plasma lipid) was both low (mean recovery 81%) and variable (70-94%), and so the results must be treated as crude estimates.
Immunological tests
Lipoprotein fractions were tested for immunoreactivity with commercially available antisera to ß-and ct-lipoprotein (Hoechst). LP-X was detected with an immunoelectrophoretic method (Seidel, Wieland & Ruppert, 1973) using an antiserum against LP-X (Hoechst) and with the 'Rapidophor all in for LP-X' test (Immuno A G Vienna, Austria).
Electron microscopy
Column fractions and centrifugal preparations were looked at with negative staining techniques. If necessary the concentrated centrifugal preparations were diluted with sodium chloride solution (150 mmol/1), mixed with an equal volume of 3% phosphotungstic acid, which was adjusted to pH 7-4 with sodium hydroxide. Samples were applied to Formvar-coated (0-4%) copper grids which were carbon-coated on the same side. They were examined with a Philips 300 electron microscope.
Results

Plasma lecithin-cholesterol acyltransferase ac tivity
The plasma LCAT activity of our normal subjects ranged from 39 to 69 nmol h _1 ml -1 with a mean activity of 51 nmol h _1 ml -1 . The plasma LCAT activity in our patients ranged from 13-5 to 93-8 nmol h" 1 ml -1 . On the basis of LCAT activity patients were arbitrarily divided into three groups: those with high (>58 nmol h _1 ml -1 , mean 72), medium (30-47 nmol h -1 ml" 1 , mean 39) and low LCAT activity (<30 nmol h _1 mM, mean 21). There was a significant negative correlation between LCAT activity and total bilirubin (r = -0-559, P < 0-02) but no significant correlation was found with other liverfunction tests.
Total plasma lipids
There was great variation in the plasma lipid concentrations found in our patients (Table 2 ). In the high LCAT group there was an increase in total lipid but the proportions of individual plasma lipids (expressed as percentage of total lipid) were close to those of normal subjects. Low and medium LCAT patients also showed hyperlipidaemia. In the low LCAT patients the relative proportions of various lipids were grossly abnormal; there was a marked elevation of free cholesterol and a low ester .-free ratio. Some patients with medium LCAT showed almost normal proportions of lipids; others had gross abnormalities.
There was a significant correlation between LCAT activity and plasma cholesteryl ester con centrations (r = 0-55, P < 0·05) and between LCAT and the ester-free ratio (r = 0-72, P < 0-01). Free cholesterol was raised in all groups but was grossly elevated in the low LCAT patients; phospholipids mirrored changes in free cholesterol. Total plasma triglycerides were highest in the high LCAT group but the differences between the groups were not significant.
Individual lipoprotein fractions
Very-low-density lipoproteins. All patients were found to have VLDL (d < 1-006) when it was isolated by preparative ultracentrifugation; but a pre-/? band (usually indicative of VLDL) was visible only in patients with high LCAT and in two of the seven patients with medium LCAT activities. Plasma triglycerides were elevated in all groups. VLDL was isolated by ultracentrifugation from patients with no pre-/? band; on subsequent electrophoresis it ran with a fast ^-mobility confirming the results of Seidel, Greten, Geisen, Wengeler & Wieland (1972) . The VLDL from high LCAT patients had a normal composition (Table  3 ). In the medium LCAT group composition was variable. The VLDL from low LCAT subjects was always abnormal, having a high protein, phospholipid and free cholesterol and a low cholesteryl ester and triglyceride. There was a significant correlation between LCAT activity and our crude estimate of the mass of total VLDL (r = 0-56, P < 0-05). Regardless of LCAT activity only one peak was found on column chromatography and no obvious abnormalities were seen on electron microscopy (although the VLDL particles from low LCAT subjects may have been more heterogeneous in size).
Low-density lipoproteins. LDL (d 1-006-1-063) from patients with high LCAT activity was normal in composition (Table 4) and morphology ( Fig. 1 ) but was present in larger amounts than in normal subjects, even allowing for the crude estimations of recovery. No LP-X was detected in these patients and only one peak was seen on agarose column chromatography. LDL from low LCAT patients was abnormal. The proportions of free cholesterol 
composition of whole very-low-density lipoproteins (VLDL)
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Subjects (n)
Normal ( and phospholipid were elevated and there was less cholesteryl ester and protein (Table 4 ). The composition of LDL from the medium LCAT group was variable but the mean values for the relative proportions were abnormal. There was a significant correlation between LCAT activity and the proportion of LDL cholesterol present as cholesteryl ester (r = 0-67, P < 0-01). The pro portion of the whole LDL fraction made up of triglyceride was similar in high, medium and low LCAT patients; in absolute terms patients with low LCAT activity had more triglyceride in the LDL fraction but free cholesterol and phospholipid were also increased and so the proportion of triglyceride was approximately the same. With a fall in LCAT activity there was a shift of triglyceride from the VLDL fraction to the LDL fraction; the ratio tri glyceride (mg) contained in VLDL/triglyceride (mg) contained in LDL was significantly correlated with LCAT activity (r = 0-65, P < 0·01). With agarose column chromatography up to three peaks were seen in LDL from patients with medium or low LCAT activity (Table 5 ). The first peak was found in three of the medium LCAT subjects and three of the low LCAT subjects; all six had elevated total plasma triglycerides. This peak consisted of large (40-100 nm) triglyceride-rich spherical particles ( Fig. 1 and Fig. 2 ) and occasion ally a few stacked discs similar to those of LP-X. These stacked discs probably represent con tamination of the large particles with LP-X as the peaks overlapped during elution from the agarose column. Material from the first peak reacted weakly against anti-/? lipoproteins but it did not react with anti-LP-X. This peak was absent in patients who did not have high triglyceride con centrations even when LCAT activity was low. In two of the low LCAT subjects who did not have 8-8 (4-12-10-3) 22-6 (17-8-26-6) * In the patients with high LCAT only one peak was eluted from the column. It corresponded to fraction no. 3 in the patients with medium and low LCAT activity. The number (n) in the medium and low LCAT patients indicates the number of patients in whom the corresponding fraction was found.
t Mean plasma triglyceride of patients with first peak (mg/100 ml) = 328-9 (medium LCAT) and 283 (low LCAT). Mean plasma triglyceride of patients without first peak (mg/100 ml) = 142 (medium LCAT) and 146 (low LCAT).
the triglyceride-rich large particle a smaller peak emerged before that of LP-X; it contained particles similar in composition to LP-X but with more protein. The second peak was similar in chemical composition and electron-microscope appearance to the obstructive lipoprotein LP-X described by other workers (Muller et al., 1974) . LP-X was found in all of the low LCAT subjects and in all but one with medium LCAT; this patient also showed normal VLDL electrophoretic mobility. The third peak, found in all patients, contained lipoprotein particles which were the same size (Fig. 2) as normal LDL. They reacted with antiserum to ß-lipoprotein. Their composition was abnormal in patients with medium or low LCAT activity as they were rich in triglycerides and poor in cholesteryl ester. The cholesteryl ester :triglyceride ratio was significantly correlated with low LCAT activity (r = 0·69, Ρ < 0-01). In patients with medium or low LCAT activity this third peak was always rich in triglyceride even if plasma triglyceride was not elevated.
High-density lipoproteins. HDL (d 1-063-1-21) was isolated by ultracentrifugation from all patients but an α-lipoprotein band was visible on electrophoresis only in patients with high LCAT and in two patients with medium LCAT activity. (These two also showed VLDL and in one of them no LP-X was found.) The concentration of HDL (crudely estimated) correlated significantly with plasma LCAT activity (r = 0-64, P < 0-01). Patients with high LCAT had HDL of normal composition (Table 6 ). It eluted as one major peak after agarose column chromatography and looked like normal HDL on electron microscopy. In two patients with high LCAT activity we found traces of a smaller particle rich in phospholipids and free cholesterol but devoid of cholesteryl esters but did not have enough material to study this by electron microscopy.
HDL from low LCAT patients and from most of those with medium LCAT were poor in cholesteryl esters but rich in phospholipid and triglyceride. Column chromatography revealed up to three peaks ( Table 7 ). The first, eluting earlier than normal HDL, was found in two of the medium LCAT patients and three of those with low LCAT activity. This fraction was rich in phospholipids and free cholesterol and poor in cholesteryl ester. On electron microscopy large particles (~20 nm) were seen, which formed stacked discs (Fig. 3) . The second peak was similar in size to normal HDL but was poor in cholesteryl esters and relatively rich in triglyceride. The third peak was found as a minor constituent of HDL in two of the medium LCAT subjects and in three of those with low LCAT 
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Normal ( * In the patients with high LCAT only one peak was eluted from the column. It corresponded to fraction no. 2 in the patients with medium and low LCAT activity. The number («) in the medium and low LCAT patients indicates the number of patients in whom the corresponding fraction was found.
activity. It was composed largely of phospholipid and protein; it also contained high amounts of tri glyceride but cholesteryl esters were either undetectable or present in very small amounts.
Discussion
Our results support our hypothesis that the changes in composition of the lipoproteins of obstructive jaundice reflect plasma LCAT activity. In patients with high LCAT activity total plasma lipids were elevated but there were few other changes; the cholesteryl ester:free cholesterol ratio was only slightly reduced, lipoprotein electrophoresis revealed a normal pattern and we could not detect LP-X. With medium or low LCAT activity the lipid and lipoprotein changes were striking; there was a high plasma cholesterol concentration due primarily to a rise in free sterol; the electrophoretic strip was abnormal in 10 of the 12 patients with medium or low LCAT activity and LP-X was present in 11 of the 12. Seidel, Gretz & Ruppert (1973) claimed that the presence of LP-X was characteristic of biliary obstruction (or 'cholestasis') whether of extrahepatic or intrahepatic origin. We were therefore surprised initially by our failure to find LP-X in our patients with high LCAT activity. Another laboratory confirmed our findings (Dr G. L. Mills, Courtauld Institute, London). We do not believe that our results were due to insensitivity of our immunoelectrophoretic method for detecting LP-X as there was additional evidence that LP-X was absent in these patients. Their LDL fraction was normal in composition, and did not show the high free cholesterol and phospholipid content charac teristic of LP-X. There was no peak in the position of LP-X with agarose column chromatography, and no particles like LP-X were seen on electron microscopy. Many other patients with 'cholestasis' have been reported to have had no detectable LP-X in the plasma (Magnani & Alaupovic, 1976; Vergani, Pietrogrande & Grondona, 1973; Ross, Murphy, Wilkinson, Mills & Sherlock, 1970; Ritland, Blomhoff, Elgjo & Gjone, 1973; Mordasini, Berthold, Schlumpf, Keller & Riva, 1975) . Seidel (1976) has also claimed that the con centration of LP-X in plasma does not correlate with LCAT activity. We cannot explain this difference between our observations. Patsch, Patsch & Sailer (1976a) and Ritland & Gjone (1975) found a reciprocal relationship between the concentration of LP-X and LCAT activity. We studied only one patient (S.S.) on two occasions; when her LCAT was high she had no LP-X but this was detected when her LCAT activity fell.
LP-X may not be the only cholesterol-and phospholipid-rich particle in the LDL of patients with obstructive jaundice and low LCAT. Patsch, Patsch, Sailer & Braunsteiner (1976b) isolated two particles, LP-X, and LP-X 2 , which differed in their lipid : protein ratio and density. Two of our patients with low LCAT activity showed a small but unusual peak on agarose column chromatography of the LDL fraction, which had a similar com position to LP-X but was richer in protein. This peak does not appear to be one of the LP-X variants described by Patsch et al., (1976b) but may represent another cholesterol-phospholipidrich variant.
Many of our patients had elevated plasma triglyceride concentrations irrespective of the level of LCAT activity. In patients with medium or low LCAT activities the excess of triglyceride was found in LDL and not, as one might have expected, in VLDL. There were two reasons for this. First, a small number of patients had large triglyceride-rich particles in their LDL. Secondly, and much more importantly, these and other patients had normal size LDL particles which contained more tri glyceride than usual. Large triglyceride-rich par ticles have been found in the LDL fraction both in liver disease (Muller et al, 1974; Kostner, Laggner, Prexl, Holasek, Ingolic & Geymayer, 1976) and in familial LCAT deficiency (Glomset et al., 1973) . The chemical composition and structure were similar, though not identical, in each case. The origin of these particles is not clear. Muller et al. (1974) claimed that they may result from a reduced activity of hepatic lipase in patients with liver disease. But this could not explain their presence in LCAT deficiency as hepatic lipase activity is normal in this condition (Greten, Degrella, Klose, Rascher, de Gennes & Gjone, 1976) .
Normal-sized LDL was found in all patients. In patients with high LCAT it was the only LDL present and was normal in composition. In patients with medium and low LCAT it was rich in tri glyceride and poor in cholesteryl ester. The cause of this abnormality is uncertain. Both triglyceride and cholesteryl ester are non-polar lipids and must form the core of the spherical LDL particle. If the particle size remains constant then increase in one of these lipids must be accompanied by a decrease in the other. Lipoprotein lipase removes tri glyceride from VLDL and the /5-apoprotein of VLDL is then incorporated into LDL. Cholesteryl ester, produced by LCAT, is also incorporated into LDL. LDL with a high triglyceride: cholesteryl ester ratio might result if the /ff-apoprotein trans ferred from VLDL carried with it more triglyceride than usual (perhaps because lipase activity was reduced). Alternatively reduction of plasma LCAT activity could have the same effect on the ratio if, as a result, less cholesteryl ester was transferred to the /?-apoprotein.
We did not measure hepatic or peripheral lipase activity but the correlation between LCAT activity and the cholesteryl ester: triglyceride ratio in these particles would support the second of the above alternatives, as did the findings in patients with familial LCAT deficiency. The normal size LDL particles in these patients are also triglyceride rich but hepatic and peripheral lipase activities are both normal (Greten et al., 1976) .
The HDL of obstructive jaundice have received less attention than the LDL fraction. a-Lipoprotein is usually absent on electrophoresis but with other techniques it can be shown that HDL is present in all patients, usually in decreased amounts. The concentration of HDL correlated with LCAT activity and this relationship is also found in normal subjects and in patients with parenchymal liver disease (Blomhoff, 1974a; Blomhoff, Skrede & Ritland, 1974) . In our high LCAT patients HDL concentrations were elevated. Only one peak was seen on column chromatography and its composition was virtually normal. With medium or low LCAT activity we found abnormalities similar to these found by Blomhoff (1974b) and Forte et al. (1974) . On column chromatography up to three peaks were seen when LCAT activity was medium or low. There was always a peak in the position of 'normal' HDL: its particles appeared normal on electron microscopy but their composition was abnormal; like the LDL in these patients they were low in cholesteryl ester and rich in triglyceride.
In five patients there was an early peak, which was shown by electron microscopy to contain stacked discs. These particles, rich in free cholesterol and phospholipid, were similar to those described in LCAT deficiency by and in cholestasis by Blomhoff (1974b) and by Forte et al. (1974) . Hamilton, Williams, Fielding & Havel (1976) perfused an isolated rat liver preparation with a fluid containing an inhibitor of LCAT activity. They also found stacked discs, which they pro posed represented nascent HDL, which become spherical when, as a result of LCAT activity, cholesteryl ester is available to move into the core. LCAT can convert these discs into spheres in vitro (Forte et al., 1974) . In five patients a peak eluted from the column after 'normal' HDL. It was rich in triglyceride and phospholipid and constituted only a small fraction of the HDL. Similar particles have been described previously in familial LCAT deficiency and in cholestasis . They may be a minor component of normal HDL (Glomset, Janssen, Kennedy & Dobbins, 1966; Norum et al, 1971) or they may be artifacts due to fragmentation of abnormal HDL (Blomhoff, 1974b) .
These results strongly suggest that lipoprotein abnormalities in obstructive jaundice reflect plasma LCAT activity, but reduction of LCAT activity cannot explain all the abnormalities. First, our high LCAT patients had elevated plasma lipids even though their lipoproteins were normal. Secondly, our low LCAT patients with prolonged obstructive jaundice had higher free cholesterol and phospho lipid concentrations than patients with familial life long absence of the enzyme. In both instances the total plasma lipid appeared disproportionately elevated.
What is the source of the excess lipid found in plasma regardless of the plasma LCAT activity? We have previously concluded that lecithin, and a small amount of cholesterol, must regurgitate into blood from the obstructed biliary tree; the lecithin would then leach out tissue cholesterol until the molar ratio of these two lipids in plasma was approximately one (Mclntyre et al., 1975) . If the patient has enough plasma LCAT to cope with this extra lipid then plasma free cholesterol and lecithin concentrations might not rise very much. Instead there might be an increase of cholesteryl ester and of the LDL which carried it in plasma. There is experimental support for this suggestion. Thompson, Jadhav, Nava & Gotto (1976) infused phospholipid intravenously into human subjects with normal plasma lipids (and presumably with normal LCAT activity). They observed an increase of cholesteryl ester and of LDL, and also a transient accumulation of phospholipid, suggesting that the LCAT was temporarily overloaded. High rates of regurgitation from the biliary tree might similarly exceed the esterification capacity in obstructed patients with high LCAT activities and this could explain why LP-X is found in some of these patients. After bile-duct ligation in rats we found not only a marked rise of plasma free cholesterol and phospholipid (which was presum ably in LP-X), but also an increase in LCAT activity and in plasma cholesteryl ester (Calandra, Martin, O'Shea & Mclntyre, 1972) .
With severe and prolonged obstruction liver function becomes impaired; LCAT activities fall, being inversely related to the concentration of plasma bilirubin. Free cholesterol, lecithin and LP-X should then accumulate in plasma as they do in LCAT deficiency. But the amount present would not depend only on LCAT activity. If there was a large amount of regurgitation from bile, plasma lecithin and free cholesterol would reach the very high concentrations found in some patients with chronic obstruction. But when the liver cells fail, bile flow and presumably regurgitation would fall and this might account for the drop in plasma lecithin and cholesterol seen with end-stage biliary obstruction.
We have little information about the factors controlling the release of LCAT from liver cells. There is evidence that it might be linked to the secretion of VLDL. Nordby, Berg, Nilsson & Norum (1976) studied isolated rat hepatocytes and found a close relationship between the release of LCAT and of triglyceride (presumably in VLDL) . Others have found a correlation between plasma triglyceride concentration and plasma LCAT ac tivity (Blomhoff, 1974a) . We also found a significant correlation between LCAT activity and plasma HDL, as reported in normal subjects and in patients with liver disease (Blomhoff, 1974a; Blomhoff, Skrede & Ritand, 1974) . The secretion of all three substances may be linked but the significance of such a relationship is not yet clear.
Plasma LCAT activities fall when the liver is damaged either by disease (Calandra, Martin & Mclntyre, 1971) or by experimental injury (Sabesin, Kuiken & Ragland, 1975) . We have therefore attributed the reduced LCAT activity seen in most of our patients to hepatocellular damage secondary to obstruction. This is suppor ted by the negative correlation between plasma LCAT activity and plasma bilirubin con centrations. We cannot explain the high LCAT seen in some patients with obstructive jaundice. In these patients VLDL and HDL were also elevated as were the concentrations of LDL and total lipid. The liver of the rat with biliary obstruction initially synthesizes more protein and lipid than that of control animals (Stakeberg, Lundborg & Schersten, 1974) but it is not known whether this protein is 'exported' into the plasma, if it involves apolipoproteins and LCAT, or whether it occurs in man.
The lipoprotein changes of obstructive jaundice may be important. Some patients develop skin xanthomata (Ahrens & Kunkel, 1949) , accumulate lipid in the sheaths of peripheral nerves (Thomas & Walker, 1965) and may deposit lipid in their kidneys. Cooper & Jandl (1966) showed that cholesterol and phospholipid is transferred into the erythrocyte membrane from the plasma of patients with obstructive jaundice. This effect on mem branes may be particularly important. If it were widespread it could contribute to the general cellular disturbance which characterizes serious liver disease of many kinds. If so then an under standing of these changes might help us in caring for the jaundiced patient.
